Prospect News: News for Halozyme Therapeutics Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Price: $0.00

Account balance: $0.00

Add to balance / Manage account

User: lxbfYeaa

Log out

Prospect News home > Main news index > All issuers starting with H > Issuers starting with H, PP only > All stories on Halozyme Therapeutics Inc. > Stories on Halozyme Therapeutics Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Halozyme Therapeutics Inc.

4/24/2007	PP	New Issue: Halozyme secures $32.1 million from private placement of stock
4/24/2007	PP	Market Commentary: Halozyme secures $32.09 million from private placement; Adaltis plans C$28 million stock offering
2/14/2007	PP	New Issue: Halozyme seals $20 million stock deal as part of distribution agreement
2/14/2007	PP	Market Commentary: EXCO plans $2 billion private placement of convertible preferreds; Vion prepares to seal $60 million issue
12/11/2006	PP	New Issue: Halozyme Therapeutics concludes $11.06 million stock sale
12/11/2006	PP	Market Commentary: Biotech deals again dominate PIPE issuance; Langer seals $28.88 million convertible offering
12/14/2005	BTPP	New Issue: Halozyme raises additional $1.45 million from direct placement
12/14/2005	PP	Market Commentary: NGAS raises $37 million in note sale; biotech deals continue to dominate PIPE offerings
12/13/2005	PP	Market Commentary: CanWest raises $22.5 million from unit deal; Halozyme to wrap $16.1 million direct offering
12/13/2005	BTPP	New Issue: Halozyme to raise $16.1 million in direct placement of stock
11/10/2004	PP	Halozyme calls warrants for 2.02 million shares
10/13/2004	PP	Market Commentary: Gastar plans for $20 million private placement financing; Halozyme places $13.9 million stock
10/13/2004	PP	New Issue: Halozyme Therapeutics sells $13.9 million of stock in private placement

©2026 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.